AGIOS PHARMACEUTICALS, INC. Annual Depreciation in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Agios Pharmaceuticals, Inc. annual/quarterly Depreciation history and growth rate from 2011 to 2023.
  • Agios Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2020 was $2.47M, a 23.4% increase year-over-year.
  • Agios Pharmaceuticals, Inc. annual Depreciation for 2023 was $6.6M, a 21.4% decline from 2022.
  • Agios Pharmaceuticals, Inc. annual Depreciation for 2022 was $8.4M, a 4.55% decline from 2021.
  • Agios Pharmaceuticals, Inc. annual Depreciation for 2021 was $8.8M, a 6.38% decline from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.6M -$1.8M -21.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $8.4M -$400K -4.55% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $8.8M -$600K -6.38% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $9.4M +$1.4M +17.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $8M +$800K +11.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $7.2M +$800K +12.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $6.4M +$692K +12.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
2016 $5.71M +$2.37M +70.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-14
2015 $3.34M +$1.98M +144% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-14
2014 $1.37M -$73K -5.07% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-16
2013 $1.44M +$261K +22.1% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 $1.18M +$378K +47.2% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-24
2011 $801K Jan 1, 2011 Dec 31, 2011 10-K 2014-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.